Patents
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
02/2013
02/13/2013CN102284061B Preparation method of heat-resisting vaccine for domestic animals
02/13/2013CN102159705B Mutant pestivirus with mutations in core gene and ns3 region
02/13/2013CN102100911B Preparation method of Cynoglossus semilaevis vibrio anguillarum vaccine
02/13/2013CN102028941B Neisseria meningitidis group B recombinant protein chimeric vaccine and preparation method thereof
02/13/2013CN101993498B Adenovirus vector avian influenza recombinant vaccine
02/13/2013CN101942417B Separated bacteriophages of enterobacter sakazakii, combination and application thereof
02/13/2013CN101810847B Inflammation-inhibiting compounds
02/13/2013CN101732707B Mercury-free Japanese encephalitis inactivated vaccine composition and application thereof
02/13/2013CN101693742B Anti-IGF-I receptor antibody
02/13/2013CN101559223B Idemic encephalitis diphtheria-pertussis-tetanus combined vaccine
02/13/2013CN101505795B Composition for modulating the expression of cell adhesion molecules
02/13/2013CN101460849B Diagnostic agent and therapeutic agent for pancreatic cancer
02/13/2013CN101405386B Tuberculosis vaccine
02/13/2013CN101394865B Compositions and methods relating to treatment of cancer and infectious diseases
02/13/2013CN101287754B Tumor-associated peptides binding promiscuously to human leukocyte antigen (HLA) class II molecules
02/13/2013CN101282992B 抗肌抑制素抗体 Anti-myostatin antibodies
02/13/2013CN101238209B 登革血清型2减毒株 Save dengue serotype 2 strain
02/13/2013CN101048498B Virosome particles comprising antigens from influenza virus and hepatitis b virus
02/12/2013US8372963 RSV F-protein and its use
02/12/2013US8372958 Opsonic and protective monoclonal and chimeric antibodies specific for lipoteichoic acid of gram posiive bacteria
02/12/2013US8372955 Purified antibody to the extracellular domain of NKp44L
02/12/2013US8372798 A stable antibody liquid comprising a precipitated immunoglobulins and water; precipitating with a biocompatible polymer; storage stability
02/12/2013US8372645 Therapeutic composition with a botulinum neurotoxin
02/12/2013US8372622 Modified vaccinia virus ankara for the vaccination of neonates
02/12/2013US8372413 Mycobacterial disease, malaria, leishmaniasis, toxoplasmosis, schistosomiasis and clonorchiasis; antiallergens; asthma
02/12/2013US8372412 Bioassay and peptides for use therein
02/12/2013US8372411 S. pneumoniae antigens
02/12/2013US8372410 S. epidermidis antigens
02/12/2013US8372409 Dendritic cell binding proteins and uses thereof
02/12/2013US8372407 Chimeric HIV fusion proteins as vaccines
02/12/2013US8372406 Antitumoral and antiviral peptides
02/12/2013US8372405 Proteins with improved solubility and methods for producing and using same
02/12/2013US8372404 Anti-C5/C5a antibodies and methods of use
02/12/2013US8372403 Humanized anti-factor D antibodies and uses thereof
02/12/2013US8372402 Mammalian receptor proteins DCRS5; methods of treatment
02/12/2013US8372401 Human antibodies that bind human TNFα
02/12/2013US8372400 Methods of treating disorders using human antibodies that bind human TNFα
02/12/2013US8372399 Bispecific antibodies and agents to enhance stem cell homing
02/12/2013US8372398 Single domain VHH antibodies against Von Willebrand Factor
02/12/2013US8372397 Methods for regulation of stem cells
02/12/2013US8372396 Antibody formulations
02/12/2013US8372393 Method of inducing a CTL response
02/12/2013US8372388 Method for preparing a stable TNF-α vaccine
02/12/2013CA2665707C Method for identification of cellular protein antigens and presence of antibodies to specific cellular protein antigens in serum
02/12/2013CA2548249C Processes for the preparation of a batch of an active pharmaceutical ingredient, a container comprising cryogranules of an allergen product, and a cryogranule of an allergen product
02/12/2013CA2469715C Opsonic monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria
02/12/2013CA2462646C Adjuvanted meningococcus compositions
02/12/2013CA2388450C Tadg-15: an extracellular serine protease overexpressed in carcinomas
02/12/2013CA2365903C Viral particles which are released after the infection with the human cytomegalovirus and the use of said particles as a vaccine
02/12/2013CA2345817C Novel methods for therapeutic vaccination
02/12/2013CA2336250C Anti-ccr2 antibodies and methods of use therefor
02/12/2013CA2304350C Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis
02/12/2013CA2274490C Non-m non-o hiv strains, fragments and applications
02/11/2013DE202012011260U1 Ranibizumab-Spritze Ranibizumab injection
02/11/2013DE202012011259U1 Bevacizumab-Spritze Bevacizumab Injection
02/07/2013WO2013020133A2 Optimized antigens of pneumocystis and use thereof
02/07/2013WO2013020132A1 Methods of treating cardiovascular and metabolic diseases
02/07/2013WO2013020090A2 STREPTOCOCCAL GLcNAc-LACKING GLYCOPOLYPEPTIDES, CELL WALL CARBOHYDRATES, STREPTOCOCCUS VACCINES, AND METHODS FOR MAKING AND USING THEM
02/07/2013WO2013020074A2 A broadly neutralizing human antibody that recognizes the receptor-binding pocket of influenza hemagglutinin
02/07/2013WO2013019954A1 Method for treating bone gap defects
02/07/2013WO2013019906A1 Methods of treating cancer using pd-1 axis binding antagonists and mek inhibitors
02/07/2013WO2013019889A2 Bovine polyclonal antibody specific for human tnf
02/07/2013WO2013019800A1 Vlps containing ligands and methods related thereto
02/07/2013WO2013019730A1 Antibodies to tip-1 and grp78
02/07/2013WO2013019710A1 Compositions and methods for the treatment of hiv
02/07/2013WO2013019669A2 Synthetic nanocarriers that generate humoral and cytotoxic t lymphocyte (ctl) immune responses
02/07/2013WO2013019648A1 Control of antibody responses to synthetic nanocarriers
02/07/2013WO2013019623A2 Methods and compositions for modulating the innate immune response and/or myogenesis in a mammalian subject
02/07/2013WO2013019603A2 Linear expression cassettes and uses thereof
02/07/2013WO2013019098A1 Helicobacter pylori proteins for diagnostic kit and vaccine
02/07/2013WO2013018894A1 Pharmaceutical composition for treatment and/or prophylaxis of cancer
02/07/2013WO2013018892A1 Drug composition for cancer treatment and/or prevention
02/07/2013WO2013018891A1 Pharmaceutical composition for treatment and/or prophylaxis of cancer
02/07/2013WO2013018889A1 Cancer treatment and/or prevention drug composition
02/07/2013WO2013018886A1 Pharmaceutical composition for treatment and/or prevention of pancreatic cancer
02/07/2013WO2013018883A1 Cancer treatment and/or prevention drug composition
02/07/2013WO2013018778A1 Cell for use in immunotherapy which contains modified nucleic acid construct encoding wilms tumor gene product or fragment thereof, method for producing said cell, and said nucleic acid construct
02/07/2013WO2013018018A1 Antitumour combination comprising ombrabulin and cetuximab, associated with radiotherapy
02/07/2013WO2013017713A1 Hrsv f protein in the stabilised pre-fusion state and specific neutralising antibodies against same
02/07/2013WO2013017591A1 Hypoallergenic variants of mal d 1, the major allergen from malus domestica
02/07/2013WO2013017570A1 Novel prrs virus inducing type i interferon in susceptible cells
02/07/2013WO2013017568A1 INFECTIOUS cDNA CLONE OF EUROPEAN PRRS VIRUS AND USES THEREOF
02/07/2013WO2013017540A1 Combination therapy for the treatment of cd19+ b-cell malignancies symptoms comprising an anti-cd19 maytansinoid immunoconjugate and rituximab
02/07/2013WO2013017053A1 Composite vaccine for preventing and treating alzheimer's disease and preparation method therefor
02/07/2013WO2013016805A1 Recombinant swine influenza virus and uses thereof
02/07/2013WO2012134520A3 Regulation of immune response by colocynthin and/or its derivatives
02/07/2013US20130036481 Use of perlecan domain v in treating amyloidogenic disease
02/07/2013US20130035755 Medical device with coating that promotes endothelial cell adherence
02/07/2013US20130035260 Genes involved in inflammatory bowel diseases and use thereof
02/07/2013US20130034610 Hydrophobic nanotubes and nanoparticles as transporters for the delivery of drugs into cells
02/07/2013US20130034598 Inhibitors of akt/pkb with anti-tumor activity
02/07/2013US20130034588 Chlamydia pneumoniae associated chronic intraocular disorders and treatment thereof
02/07/2013US20130034587 Methods for treatment of incontinence associated with sexual activity
02/07/2013US20130034585 Bovine Herpes Virus Vaccine With Multiple Mutations
02/07/2013US20130034584 Agent for use in the topical or local treatment of cervical dysplasias
02/07/2013US20130034583 Compositions, methods and uses for expression of enterobacterium-associated peptides
02/07/2013US20130034582 Reverse genetics methods for virus rescue
02/07/2013US20130034581 Genetically engineered swine influenza virus and uses thereof
02/07/2013US20130034580 Novel formulations which stabilize and inhibit precipitation of immunogenic compositions
02/07/2013US20130034579 Immunogenic compositions and related methods